title: Antimicrobial susceptibility testing in Sweden. II. Species-related zone diameter breakpoints to avoid interpretive errors and guard against unrecognized evolution of resistance.
abstract: The Swedish Reference Group for Antibiotics appointed a subcommittee on methodology (SRGA-M) in 1987 to investigate ways of defining interpretive breakpoints for antimicrobial susceptibility testing. The minimum inhibitory concentration (MIC) breakpoints for susceptibility categories are mainly based on pharmacological properties of the antibiotic, and they are, with few exceptions, valid for all species. However, for several species the MIC breakpoints have failed to distinguish strains with reduced susceptibility from normal susceptible strains. Disk diffusion is the routine method for susceptibility testing in Sweden. Studies of distribution of MICs and zone diameters for clinically important bacterial species have resulted in an emphasis on resistance rather than on susceptibility. The SRGA-M chose to place the zone diameter breakpoints close to the native (often susceptible) population of each species or group of related species. Such species-related zone diameter breakpoints used for susceptibility categories no longer correspond to the pharmacological MIC breakpoints, but divide each species into the fully susceptible (native) population and into those isolates/populations that have acquired a resistance mechanism, resulting in high- or low-grade resistance. By this method the risk of reports of false susceptibility is minimized and early detection of the emergence of antibiotic resistance is ensured.
authors.affiliation: Department of Clinical Microbiology, Karolinska Institute, Stockholm, Sweden.
authors.forename: S
authors.initials: S
authors.lastname: Ringertz
authors.forename: B
authors.initials: B
authors.lastname: Olsson-Liljequist
authors.forename: G
authors.initials: G
authors.lastname: Kahlmeter
authors.forename: G
authors.initials: G
authors.lastname: Kronvall
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001424:Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy; D003951:Diagnostic Errors; D004352:Drug Resistance, Microbial; D017408:Guidelines as Topic / Q000592:standards; D008826:Microbial Sensitivity Tests / Q000379:methods* / Q000592:standards; D013548:Sweden
chemical_list: D000900:Anti-Bacterial Agents